Ascending Wedge Reversal.
Volume is there and ready to go.
Generic opioid manufacturers have been beaten down recently over fear of a copious monetary fine, but MNK has an established diverse profile.
Do NOT miss this stock when it runs.
Break above $4.15 and were off
Long Term Target: $12.90
Volume is there and ready to go.
Generic opioid manufacturers have been beaten down recently over fear of a copious monetary fine, but MNK has an established diverse profile.
Do NOT miss this stock when it runs.
Break above $4.15 and were off
Long Term Target: $12.90